Pro108Ser mutation of SARS-CoV-2 3CLpro reduces the enzyme activity and ameliorates the clinical severity of COVID-19.
Abe K, Kabe Y, Uchiyama S, Iwasaki YW, Ishizu H, Uwamino Y, Takenouchi T, Uno S, Ishii M, Maruno T, Noda M, Murata M, Hasegawa N, Saya H, Kitagawa Y, Fukunaga K, Amagai M, Siomi H, Suematsu M, Kosaki K; Keio Donner Project.
Abe K, et al. Among authors: saya h.
Sci Rep. 2022 Jan 25;12(1):1299. doi: 10.1038/s41598-022-05424-3.
Sci Rep. 2022.
PMID: 35079088
Free PMC article.